What is he best known for?
The fields of study he is best known for:
- Surgery
- Cancer
- Internal medicine
Lars Påhlman focuses on Surgery, Colorectal cancer, Radiation therapy, Randomized controlled trial and Rectum.
His Surgery research includes elements of Cancer and Clinical trial.
His Colorectal cancer research incorporates elements of Laparoscopy, Chemotherapy and MEDLINE.
His Radiation therapy research is multidisciplinary, incorporating perspectives in Regimen, Preoperative care, Adverse effect and Total mesorectal excision.
His work in the fields of Randomized controlled trial, such as Randomization, overlaps with other areas such as Uncomplicated diverticulitis.
His study in Rectum is interdisciplinary in nature, drawing from both Multicenter trial, Microsatellite instability, DNA mismatch repair, Abdominoperineal resection and Survival analysis.
His most cited work include:
- Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer (3158 citations)
- Improved survival with preoperative radiotherapy in resectable rectal cancer. (1935 citations)
- Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. (1685 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Surgery, Colorectal cancer, Internal medicine, Rectum and Radiation therapy.
His Surgery research incorporates themes from Clinical trial and General surgery.
His Colorectal cancer study combines topics from a wide range of disciplines, such as Survival rate, Pathology and Stage.
He interconnects Gastroenterology and Oncology in the investigation of issues within Internal medicine.
His work carried out in the field of Radiation therapy brings together such families of science as Regimen, Preoperative care and Perioperative.
His Randomized controlled trial research includes themes of Colectomy and Laparoscopy.
He most often published in these fields:
- Surgery (56.79%)
- Colorectal cancer (51.79%)
- Internal medicine (29.64%)
What were the highlights of his more recent work (between 2009-2021)?
- Colorectal cancer (51.79%)
- Surgery (56.79%)
- Internal medicine (29.64%)
In recent papers he was focusing on the following fields of study:
Colorectal cancer, Surgery, Internal medicine, Randomized controlled trial and Radiation therapy are his primary areas of study.
His study on Colorectal cancer is covered under Cancer.
His Surgery research is multidisciplinary, incorporating elements of Total mesorectal excision and General surgery.
His research in Internal medicine intersects with topics in Gastroenterology and Oncology.
His Randomized controlled trial study combines topics in areas such as Rectum, Clinical trial and Diverticulitis.
His Radiation therapy research incorporates elements of Colonoscopy, Perioperative and Pathological.
Between 2009 and 2021, his most popular works were:
- Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial (1002 citations)
- Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (815 citations)
- Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis (297 citations)
In his most recent research, the most cited papers focused on:
- Surgery
- Cancer
- Internal medicine
His primary scientific interests are in Colorectal cancer, Surgery, Cancer, Radiation therapy and Total mesorectal excision.
His work carried out in the field of Colorectal cancer brings together such families of science as Survival rate, Mortality rate, Randomized controlled trial and Gynecology.
His study in the fields of Chemoradiotherapy, Preoperative care and Stage under the domain of Surgery overlaps with other disciplines such as In patient.
His Cancer research is multidisciplinary, incorporating elements of Developed country, Immunology, Growth factor, GDF15 and Survival analysis.
His study brings together the fields of Clinical trial and Radiation therapy.
His research in Total mesorectal excision intersects with topics in Neoadjuvant therapy, Regimen and Cumulative incidence.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
